J Bone Miner Res 35(8):14151423 Herrou J, Mabilleau G, Lecerf JM, Thomas T, Biver E, Paccou J (2024) Narrative review of effects of Glucagon-Like Peptide-1 Receptor Agonists on bone health in people living with obesity
In real-world practice, several patients can all ask about the same medication and still need very different plans: One may have significant GI sensitivity and need slower escalation
Morning injection (Monday at 7 AM) puts peak side effects on Tuesday late afternoon, which some patients prefer because they can address symptoms during waking hours rather than disrupted sleep
May reduce common opioid risks like dependence and sedation
Glutathione kinetics in normal man and in patients with liver cirrhosis
There's ongoing research in autoimmune and other conditions, but these are kind of still the strongest data that we have for these medications